Trial intelligence / Profile preview

Metoclopramide dose finding for acute migraine

NCT00682734Phase 3Completed

Sponsor
Montefiore Medical Center
Start
Apr 2008
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of metoclopramide in migraine (3 arms), sponsored by Montefiore Medical Center. Primary endpoint: Pain Intensity Score at 60 minutes. Started Apr 2008; status: completed.

02

Drugs

metoclopramide
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00682734.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00682734.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call